Rare diseases
Investigational molecules
Locations
Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
GermanyStudy on Midostaurin and Gemtuzumab Ozogamicin for Adults with Acute Myeloid Leukemia
GermanyStudy on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation
GermanyStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
GermanyStudy of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation
GermanyStudy of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock
GermanyStudy on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal
GermanyStudy on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease
GermanyStudy on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations
GermanyStudy of Dostarlimab for Patients with Untreated Locally Advanced Rectal Cancer
GermanyStudy on the Effects of Prasinezumab in Patients with Early Parkinson's Disease
GermanyStudy Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
